However, other authors have suggested the combination of RNA panels with classical biomarkers for the prediction of NASH, specifically miR-122, miR-192, and miR-21 together with ALT and cytokeratin-18-Asp396 (52). This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.